Literature DB >> 29103869

Missing a GOLDen opportunity in gastric cancer.

Elizabeth Smyth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29103869     DOI： 10.1016/S1470-2045(17)30719-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

Review 1.  Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.

Authors:  Ankur K Nagaraja; Osamu Kikuchi; Adam J Bass
Journal:  Cancer Discov       Date:  2019-11-14       Impact factor: 39.397

2.  Genomic loss of heterozygosity and survival in the REAL3 trial.

Authors:  Elizabeth C Smyth; Catherine Cafferkey; Andrea Loehr; Tom Waddell; Ruwaida Begum; Clare Peckitt; Thomas C Harding; Minh Nguyen; Alicia F Okines; Mitch Raponi; Sheela Rao; David Watkins; Naureen Starling; Gary W Middleton; Jonathan Wadsley; Wasat Mansoor; Tom Crosby; Andrew Wotherspoon; Ian Chau; David Cunningham
Journal:  Oncotarget       Date:  2018-11-30

3.  Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer.

Authors:  Zhiyuan Xu; Qiuli Chen; Lilu Shu; Chunye Zhang; Wenjun Liu; Peter Wang
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

Review 4.  PARP inhibitors in gastric cancer: beacon of hope.

Authors:  Yali Wang; Kun Zheng; Yongbiao Huang; Hua Xiong; Jinfang Su; Rui Chen; Yanmei Zou
Journal:  J Exp Clin Cancer Res       Date:  2021-06-24

Review 5.  Harnessing biomarkers of response to improve therapy selection in esophago-gastric adenocarcinoma.

Authors:  Caroline Yk Fong; Ian Chau
Journal:  Pharmacogenomics       Date:  2021-06-14       Impact factor: 2.638

Review 6.  Precision medicine in gastric cancer.

Authors:  Patrizia Bonelli; Antonella Borrelli; Franca Maria Tuccillo; Lucrezia Silvestro; Raffaele Palaia; Franco Maria Buonaguro
Journal:  World J Gastrointest Oncol       Date:  2019-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.